| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |